GlassScriptPhysician profile
Paul J Super
NPI 1649499807
$2,536.13
in general payments reported to CMS, 2019-2025
15 companies · $504 in 2025
The $504 reported for 2025 was more than what 77% of Optometrist providers received nationally (typical 2025 total: $204).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $523 · 2020: $60.86 · 2021: $199 · 2022: $629 · 2023: $521 · 2024: $99.39 · 2025: $504.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,090 · Entertainment: $34.54.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,089.51 |
| Entertainment | $34.54 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Johnson & Johnson Vision Care, INC. | $601.57 | 2019-2025 | Acuvue |
| Glaukos Corporation | $429.76 | 2022-2025 | Photrexa Viscous and Photrexa, Kxl System (Not Refurbished) |
| Bausch & Lomb, A Division of Bausch Health US, LLC | $296.58 | 2019-2021 | |
| Coopervision INC. | $170.04 | 2019-2023 | Myday Contact Lens |
| Bausch & Lomb Americas INC. | $168.62 | 2024-2025 | Biotrue One Day, Infuse, Miebo |
| Sight Sciences, INC. | $149.96 | 2023 | Omni Surgical System |
| Alcon Vision LLC | $146.60 | 2022-2025 | Precision 1, Dailies Total1 |
| Rxsight INC | $146.21 | 2023 | Rxsight Light Delivery Device (Ldd), Rxsight Injector Cartridge, Rxsight Injector Handpiece |
| Oyster Point Pharma, INC. | $121.90 | 2023 | Tyrvaya |
| Regeneron Healthcare Solutions, INC. | $119.16 | 2019 | |
| Abbvie INC. | $53.07 | 2022 | |
| Carl Zeiss Meditec Ag | $38.80 | 2020 | |
| Dompe US, INC. | $37.43 | 2024 | Oxervate |
| Optos, INC. | $34.54 | 2025 | Oct Ophthalmoscope, Panoramic Ophthalmoscope, Nfc-700 |
| Eyevance Pharmaceuticals LLC | $21.89 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Paul Super listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.